Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000327BKPyvENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS46000867BKPyvENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS10012871HBVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS10033544HBVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS10039382HBVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS30002051HIVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS30032928HIVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS30032929HIVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS30032930HIVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TVIS20050554HPVENSG00000135503.13protein_codingACVR1BNoYes91P36896
TCGA Plot Options
Drug Information
GeneACVR1B
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0000665
UniProt IDP36896
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830